Orchestra BioMed
OBIO
OBIO
63 hedge funds and large institutions have $90.1M invested in Orchestra BioMed in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% more funds holding
Funds holding: 52 → 63 (+11)
3.99% less ownership
Funds ownership: 42.42% → 38.43% (-4%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
63
Holding in Top 10
–
Calls
$329K
Puts
$76K
Top Buyers
| 1 | +$823K | |
| 2 | +$693K | |
| 3 | +$653K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$495K |
| 5 |
Goldman Sachs
New York
|
+$446K |
Top Sellers
| 1 | -$2.49M | |
| 2 | -$1.47M | |
| 3 | -$955K | |
| 4 |
Renaissance Technologies
New York
|
-$925K |
| 5 |
PA
Perceptive Advisors
New York
|
-$667K |
